Haoxi Health Technology Ltd Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Reporting Calendar
| Event | Expected Date |
|---|---|
| Fiscal Year 2026 Annual Results (Form 20-F Filing) | 31 Oct 2026 |
Monitoring Framework
Key Performance Indicators
Net Revenue Annually33.8M
Gross Margin Annually472.0%
Net Loss Annually-6.9M
Watch Items
- Credit Loss Allowance on Prepaid Advertising and Third-Party LoansTrigger: Exceeding $6.0 millionAction: Review credit risk policies, tighten counterparty screening, and reassess advance payment terms.
- Nasdaq Minimum Bid Price ComplianceTrigger: Closing bid price below $1.00 for 30 consecutive business daysAction: Monitor stock price post-reverse split and evaluate corporate actions to maintain listing status.
Research as of 20 Jun 2026